Larvol Delta - CA2400009-A-Study-of-Navlimetostat-BMS986504-Alone-or-in-Combination-With-Izalontamab-Brengitecan-in-Participants-With-Pretreated-Advanced-or-Metastatic-Nonsmall-Cell-Lung-Cancer-NSCLC-With-Homozygous-MTAP-Deletion-or-MTAP-Loss-MountainTAP9

Benlysta (belimumab) - GSK

Rituxan (rituximab) - Roche

cyclophosphamide - Generic mfg.

Saphnelo (anifrolumab-fnia) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42756695

Balakrishnan Navaneethakrishnan; Sabarinath Mahadevan; Saranya Chinnadurai

Sep 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next